Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery Device

Viatris

Status and phase: Withdrawn; Phase 3

Conditions: Ocular Hypertension; Glaucoma, Open-Angle

Treatments: Drug: Xalatan

Study type: Interventional

Funder types: Industry

Identifiers

NCT00283764

A6111086

Details and patient eligibility

About

Compare the antihypertensive efficacy of two methods for instilling Xalatan eyedrops

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of primary open angle glaucoma or ocular hypertension in 1 or both eyes

Exclusion criteria

• History of closed/barely open anterior chamber angle or a history of angle closure

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind